Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Enterprise Value: 2016-2024

Historic Enterprise Value for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $288.1 million.

  • Organogenesis Holdings' Enterprise Value rose 28.90% to $467.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $135.7 million, marking a year-over-year increase of 73.33%. This contributed to the annual value of $288.1 million for FY2024, which is 33.88% down from last year.
  • Organogenesis Holdings' Enterprise Value amounted to $288.1 million in FY2024, which was down 33.88% from $435.7 million recorded in FY2023.
  • Organogenesis Holdings' Enterprise Value's 5-year high stood at $2.1 billion during FY2020, with a 5-year trough of $195.8 million in FY2022.
  • Over the past 3 years, Organogenesis Holdings' median Enterprise Value value was $288.1 million (recorded in 2024), while the average stood at $306.5 million.
  • In the last 5 years, Organogenesis Holdings' Enterprise Value soared by 360.71% in 2020 and then slumped by 81.77% in 2022.
  • Yearly analysis of 5 years shows Organogenesis Holdings' Enterprise Value stood at $2.1 billion in 2020, then slumped by 48.82% to $1.1 billion in 2021, then crashed by 81.77% to $195.8 million in 2022, then surged by 122.54% to $435.7 million in 2023, then plummeted by 33.88% to $288.1 million in 2024.